<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Secura Bio, Inc.; Withdrawal of Approval of Relapsed or Refractory Follicular Lymphoma Indication for COPIKTRA</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Secura Bio, Inc.; Withdrawal of Approval of Relapsed or Refractory Follicular Lymphoma Indication for COPIKTRA</h1>
    <p class="timestamp">Published: 2022-04-13 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing that it is withdrawing approval of the relapsed or refractory follicular lymphoma indication for COPIKTRA (duvelisib) Capsules, approved under new drug application 211155, held by Secura Bio, Inc., 1995 Village Center Circle, Suite 128, Las Vegas, NV 89134. Secura Bio, Inc. voluntarily requested that the Agency withdraw approval of this indication and has waived its opportunity for a hearing.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-07931</p>
    <p><strong>Publication Date:</strong> 2022-04-13</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/04/13/2022-07931/secura-bio-inc-withdrawal-of-approval-of-relapsed-or-refractory-follicular-lymphoma-indication-for">https://www.federalregister.gov/documents/2022/04/13/2022-07931/secura-bio-inc-withdrawal-of-approval-of-relapsed-or-refractory-follicular-lymphoma-indication-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-07931</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
